Clinical trial Recruiting at 1 site Observational Ages 18 to 100

Monitoring blood vessel function and brain blood flow in patients with brain injuries

Official title: Correlation Between Noninvasive Blood Vessel Functionality Parameters and Cerebral Hemodynamics in Neurocritical Care Patients

Run by University of Louisville · NCT06511804 · Data updated 2026-11-12

This study is testing a new way to monitor blood flow and oxygen levels in the brains of patients with serious brain injuries to help doctors understand their condition better.

Quick facts

Study typeObservational
Ages18 Years to 100 Years
SexAll
Enrollment25 (estimated)
SponsorUniversity of Louisville
Academic / other
Locations1 site (Louisville, Kentucky)
StatusRecruiting
StartedNovember 17, 2024
Main results expectedDecember 30, 2025
Study endsJune 30, 2026
Registry record updatedMay 30, 2025
Trial IDNCT06511804 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults over 18 with a clinical diagnosis of traumatic brain injury, stroke, brain hemorrhage, or brain tumors who are undergoing continuous blood pressure and intracranial pressure monitoring.

Probably not a fit

Patients without a clinical diagnosis of the specified neurological conditions or those not requiring continuous monitoring may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study utilizes the Mespere LifeSciences NeurOs Cerebral Oximetry system to noninvasively monitor blood vessel functionality in patients with traumatic brain injury, stroke, brain tumors, and brain bleeding. By placing sensors on the patients' foreheads, the study aims to gather data on cerebral oxygen saturation and blood volume, correlating these with intracranial pressure and mean arterial pressure. The goal is to enhance understanding of cerebral hemodynamics and autoregulation in neurocritical care settings.

Why it matters

Potential benefit: If successful, this study could lead to improved monitoring and management of brain injuries, potentially enhancing patient outcomes.

How similar studies have gone: While similar noninvasive monitoring approaches have been explored, this specific correlation of blood vessel functionality with cerebral hemodynamics in neurocritical care is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Subjects who meet all the following inclusion criteria may be included:

1. Adults (\> 18 years of age);
2. Able and willing to provide written informed consent for participation by self or legally authorized representatives.
3. Clinical diagnosis of traumatic brain injury (TBI), brain hemorrhage, brain tumor, neurotrauma (including closed head injuries, penetrating head injuries, or other forms of neurotrauma), hemorrhage (intracerebral or subarachnoid), or stroke.
4. Continuous Blood Pressure Monitoring: Patients must have continuous blood pressure monitoring in place during the study period, obtained from an arterial line. This criterion ensures that we have real-time data on mean arterial pressure (MAP) and systolic pressure (SBP).
5. Intracranial Pressure (ICP) Monitoring: Patients must have intracranial pressure (ICP) monitoring in place during the study period. This criterion ensures that we can assess the correlation between our blood vessel functionality parameters (VDC, VR, and VRx) and ICP, a key indicator of intracranial dynamics.

Exclusion Criteria:

1. Subjects who meet any of the following exclusion criteria will be excluded:
2. Expected to be at increased risk due to study participation (e.g. due to hemodynamic instability), in the medical opinion of an investigator;
3. Pregnant as determined per site standard practice;
4. Previously participated in this study, or are enrolled in another research study that could be expected to interfere with participation, in the opinion of the investigator;
5. Require or are anticipated to require emergent medical care in which study participation may reasonably delay his/her medical care or increase risk or unfavorable outcome, in the opinion of the investigator;
6. Allergy to adhesive tape;
7. Ongoing photodynamic therapy.

Where it's running

  • University of Louisville Health
    Louisville, Kentucky, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.